U.S. market Closed. Opens in 6 hours 3 minutes

HOTH | Hoth Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of RevenueN/A66.83K46.87M25.87K31.62K28.25K
Gross ProfitN/A-66.83K-46.87M-25.87K-31.62K-28.25K
Operating Expenses7.69M11.07M14.10M7.30M7.71M2.50M
Selling, General & Admin4.21M6.13M6.57M3.96M5.06M1.22M
Research & Development3.48M4.93M7.53M2.89M2.12M1.02M
Other Operating ExpensesN/A451.14K-212.26K454.21K538.58K258.71K
Operating Income-7.69M-11.07M-14.10M-7.30M-7.71M-2.50M
Other Expenses / Income-153.15K-306.40K-212.26K104.16K10.36KN/A
Before Tax Income-7.85M-11.37M-14.31M-7.20M-7.70M-2.50M
Income Tax Expenses-7.69K305.41K-1.00-205.25K-10.36KN/A
Net Income-7.85M-11.68M-14.31M-7.20M-7.69M-2.50M
Interest ExpensesN/A305.41KN/AN/AN/AN/A
Basic Shares Outstanding3.41M1.20M893.20K494.51K366.58K376.98K
Diluted Shares Outstanding3.41M1.20M893.20K494.51K366.58K376.98K
EBITDA-153.15K-10.68M-14.10M-7.30M-7.72M-2.49M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-7.85M-11.07M-14.31M-7.40M-7.70M-2.50M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙